Melhores podcasts sobre Levine Media Group (2024)

1
PT561 – Psychedelics Lately – Massachusetts' Question 4 and Updates in Psychedelics and Chronic Pain, with Joe Moore & Kyle Buller 55:18

38m ago55:18

55:18

In this episode, Joe and Kyle finally meet up again for the first episode of Psychedelics Lately: the updated version of the much-missed Psychedelics Weekly, where they’ll meet each month to talk about the most interesting stories in psychedelics. The main story this month is the fate of Massachusetts’ Question 4: Regulated Access to Psychedelic Su…

1
A BET on a Novel Approach to Treat Autoimmune Conditions 24:40

5d ago24:40

24:40

The BET family of proteins regulates gene expression. Their overexpression has been implicated in both cancer and inflammatory diseases. Vyne Therapeutics is developing oral and topical BET inhibitors that treat inflammatory conditions ranging from rheumatoid arthritis to the skin condition vitiligo. We spoke to Vyne CEO David Domzalski and Vyne Ch…

1
PT560 – Philosophy and Psychedelics: Can Metaphysics Bring Meaning to Non-Ordinary States?, with Dr. Peter Sjöstedt-Hughes 1:01:40

23h ago1:01:40

1:01:40

In this episode, Joe interviews Dr. Peter Sjöstedt-Hughes: philosopher, lecturer at the University of Exeter, co-director of the Breaking Convention conference, and author who most recently co-edited Philosophy and Psychedelics: Frameworks for Exceptional Experience. He discusses how the work of William James and an early psilocybin experience led …

1
Stranger Ranger #2 - Night of the Trollbadgers | Mark Bell Interview 19:40

7d ago19:40

19:40

ABOUT STRANGER RANGER #2 - NIGHT OF THE TROLLBADGERS STRANGE RANGER #2 is a 32-page, full-color supernatural adventure comic about park ranger Agatha, and her friends Gord, the were-moose and Esme, the woodland magical creature. They find Dusk River Park overrun by the chaotic trollbadgers who are causing trouble and insanity! Written by Mark Bell …

1
PT559 – The Penn Psychedelics Collaborative and the Power of Interdisciplinary Connections, with Taylor Andrews Flatt, PMHNP, Victor Pablo Acero, Ph.D., Jackie Tileston, and Michael Baime, MD 40:45

5d ago40:45

40:45

In this episode, Joe interviews 4 members of the Penn Psychedelics Collaborative: Co-Founder, Taylor Andrews Flatt, PMHNP; Associate Director, Victor Pablo Acero, Ph.D.; Professor in Fine Arts and Co-Director of the Weitzman School of Design, Jackie Tileston; and Executive Director and Director of the Penn Program for Mindfulness, Michael Baime, MD…

1
Using AI and Synthetic Biology to Go Where Antibody Therapies Can’t 57:58

11d ago57:58

57:58

Monoclonal antibodies have been an important addition to the biomedical arsenal, but these therapies have limited ability to target a group of cell surface receptors known as GPCRs. Aikium is developing a new class of therapies known as SeqR proteins that offer an alternative to antibody-based drugs and can bind to intrinsically disordered regions …

1
Cell Therapies that Can Do a Solid for People with Cancer 51:49

12d ago51:49

51:49

In August, the U.S. Food and Drug Administration approved Adaptimmune’s Tecelra, the first engineered cell therapy to treat a solid tumor. The T cell receptor gene therapy is approved to treat synovial sarcoma, a rare soft tissue cancer that most often affects young adults. We spoke to Adrian Rawcliffe, CEO of Adaptimmune, about the approval, how T…

1
PT558 – What You Need to Know About Massachusetts' Question 4 and the Natural Psychedelic Substances Act, with Graham Moore and Jamie Morey 1:13:56

8d ago1:13:56

1:13:56

In this episode, Joe interviews two people on the frontlines of the campaign for Massachusetts' Question 4: The Natural Psychedelic Substances Act: Graham Moore and Community Engagement Director, Jamie Morey. They discuss the specifics of the initiative, listed on the ballot as the “Limited Legalization and Regulation of Certain Natural Psychedelic…

1
PT557 – Psychedelic Education Through a Healing Justice Lens, with Diana Quinn, ND 1:11:59

13d ago1:11:59

1:11:59

In this episode, Joe interviews Diana Quinn, ND: naturopathic doctor, healing justice practitioner, and director of clinical education at the Naropa Center for Psychedelic Studies, where she directs their Psilocybin Facilitator Training certificate program. She discusses her path from anthropology to naturopathy, and eventually to psychedelics and …

1
Going to Extremes to Discover New Drugs 31:38

19d ago31:38

31:38

Hibernation is not just a matter of deep sleep. Animals that hibernate are able to do so without suffering damage to tissue and muscle. Understanding the biology of hibernation can unlock potential insights into obesity, heart attack and stroke, muscle atrophy, neuroprotection, and longevity. Fauna Bio is studying genomic data from so-called "extre…

1
PT556 – The FDA, MDMA, and Public Perception: Was the FDA Fair to Lykos?, with Rick Doblin, Ph.D. 1:13:02

15d ago1:13:02

1:13:02

In this episode, Joe interviews Rick Doblin, Ph.D.: founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS), and former board member at Lykos Therapeutics, MAPS’ public benefit subsidiary. Doblin tells his side of the story: that the FDA’s concerns with double blinding not working had been fully addressed ahead of …

1
PT555 – Protecting Indigenous Wisdom: Rethinking Psychedelic Legalization, with Gabriela Galindo 1:16:16

24d ago1:16:16

1:16:16

In this episode, Kyle interviews Gabriela Galindo: program coordinator of FLOWS (Foundations for Leaders Organizing for Water and Sustainability), an organization working towards social and environmental justice, ecosystem restoration, community building, and the preservation and protection of Indigenous medicines. She discusses her entry point to …

1
Unlocking Market Access with AI 53:38

25d ago53:38

53:38

Rick Lloyd, founder and senior healthcare advisor of Range Health Advisors, sits down with Amar Drawid to discuss the intricacies of market access in the pharmaceutical industry, the importance of data analytics and AI in navigating the complexities of pricing and reimbursement, and how real-world evidence may help address the challenges faced by p…

1
Targeting Senescent Cells to Treat Aging-Related Diseases 31:44

26d ago31:44

31:44

Senescent cells, ones that no longer divide but are metabolically active, are associated with aging. They are also implicated in a broad range of aging-related diseases including cancer, diabetes, and neurodegenerative conditions. In the case of cancer, these cells can help protect tumors from a person’s immune system. Immorta Bio is seeking to add…

1
PT554 – The Hero's Journey: Finding Your Story in Psychedelic Healing, with Mareesa Stertz 1:06:51

27d ago1:06:51

1:06:51

In this episode, Joe interviews Mareesa Stertz: lead of strategy/communications at the Global Psychedelic Society, co-founder of Lucid News, and filmmaker, currently finalizing her second feature film, “Confessions of a Psychonaut.” She discusses her path to wanting to create the film: how she always felt like something was wrong with her but didn’…

1
PT553 – Healing Psychedelics: Where Science Meets Spirit, with Micah Stover & Craig Heacock, MD 1:11:57

26d ago1:11:57

1:11:57

In this episode, Joe interviews Micah Stover: certified psychedelic somatic therapist and author of the upcoming book, Healing Psychedelics: Innovative Therapies for Trauma and Transformation; and Craig Heacock, MD: adolescent, adult, and addiction psychiatrist, and host of the Back from the Abyss podcast. Stover discusses the inspiration for the b…

1
Ensuring Successful Implementation of AI 52:49

1M ago52:49

52:49

Anastasia Christianson, AI and data analytics senior consultant and strategic advisor to life sciences and healthcare companies, sits down with Amar Drawid to discuss the integration of AI in the pharmaceutical industry, the importance of organizational models, and why its important for teams across an organization to co-create rather than to work …

1
Bringing Cellular Diversity into Sharper Focus 30:35

1M ago30:35

30:35

From cell to cell within a given tissue, variability exists. Single-cell sequencing technologies from 10X Genomics is helping researchers and drug developers understand cellular diversity in tissue once thought to be made up of homogenous populations. This has the potential to lead to new understandings of diseases, open up new targets for drug dev…

1
PT552 – The Globalization of Ayahuasca, Psychedelic Parenting, and the Power of Ceremony, with Glauber Assis, Ph.D. 1:42:55

29d ago1:42:55

1:42:55

In this episode, David interviews Glauber Assis, Ph.D.: research associate at the Interdisciplinary Group for Psychoactive Studies, director of the Psychedelic Parenthood community, Vital instructor, and leader of Jornadas de Kura, a plant medicine center in Brazil. He talks about growing up in Brazil in the shadows of colonialism, and how he felt …

1
PT551 – Tripped: The Connection Between LSD, Nazi Germany, and MKUltra, with Norman Ohler 1:02:39

1M ago1:02:39

1:02:39

In this episode, Joe interviews award-winning novelist and screenwriter, Norman Ohler. Following in the footsteps of "Blitzed: Drugs in the Third Reich," his newest book, "Tripped: Nazi Germany, the CIA, and the Dawn of the Psychedelic Age," tells the story of how the Nazi’s passion for methamphetamine turned into a curiosity about LSD, and how the…

1
Developing Cancer Therapies for When Damage Control Goes Awry 18:09

1M ago18:09

18:09

The DDR pathway plays a critical role in repairing DNA damage in healthy cells that would otherwise cause mutations or cell death. When this pathway is altered and becomes unable to repair this damage, mutated cells can grow out of control and become cancerous. They can also be more resistant to standard chemotherapies and radiation. Aprea Therapeu…

1
Delivering the Goods 36:06

1M ago36:06

36:06

Nearly 70 percent of patients with chronic conditions fail to take their medicines as prescribed. This can lead to poor outcomes and greater healthcare costs. Vivani Medical, which has developed implantable drug delivery technology, said it can provide steady drug release for up to six months with a single implant. This not only can address the pro…

1
PT550 – Intention, Making Space for Integration, and Finding Joy in the Mundane, with Lana Pribic, M.Sc, CPC 1:14:48

1M ago1:14:48

1:14:48

In this episode, Kyle interviews Lana Pribic, M.Sc: host of the Modern Psychedelics podcast, certified professional life coach, and founder of Kanna Wellness. She talks about her early days of rave culture and MDMA, to exploring other substances, to where she is today: finding joy in the simple things in life, embracing recreational psychedelics, a…

1
PT549 – Why Did the FDA Reject MDMA-Assisted Therapy for PTSD?, with Ingmar Gorman, Ph.D. 1:03:06

1M ago1:03:06

1:03:06

In this episode, Joe interviews Ingmar Gorman, Ph.D.: clinical psychologist and co-founder and CEO of Fluence, a psychedelic education company. Gorman served as a co-principal investigator and study therapist on MAPS’ Phase II and III clinical trials for MDMA-assisted psychotherapy for PTSD, and works with drug sponsors: training, developing the co…

1
PT548 – Finding Your Soul's Purpose: Harnessing Psychedelic Insights for Professional Growth, with Beth Weinstein 1:42:50

2M ago1:42:50

1:42:50

In this episode, Kyle interviews Beth Weinstein: spiritual business coach, host of the “Medicine For These Times” podcast, and founder of the Psychedelics, Sacred Medicines, Soul’s Purpose & Business summit. She talks about a pattern she noticed of people working with psychedelics and seeing progress on what they set out to heal, but with a short-l…

1
PT547 – Coaching, Fractal Inquiry, and How to Create Your Own Psychedelic Integration Circle, with Daniel Shankin 1:13:45

2M ago1:13:45

1:13:45

In this episode, David interviews Daniel Shankin: psychedelic integration coach, Vital instructor, and founder and director of Tam Integration. He talks about the underrated importance of integration circles, how he created Tam Integration out of a personal need for them, how simple it can be for people to create their own groups, and how open-ende…

1
Tackling the New Bottleneck of Drug Discovery 57:20

2M ago57:20

57:20

Markus Gershater, chief scientific officer and co-founder of Synthace sits down with Amar Drawid to discuss Synthace’s AI-based platform that enables drug developers to design complex experiments, run them, and capture and analyze the data all in an automated way.Por Levine Media Group

1
Swimming in the New Oil 22:26

2M ago22:26

22:26

One of the key obstacles to developing new drugs and diagnostics is the lack of access to longitudinal biological and clinical patient data. Culmination Bio, a spin-out of Intermountain Health, is building the largest patient data platform with more than 40 years of de-identified patient electronic health records and biospecimen data. We spoke to L…

1
PT546 – Psychedelic Outlaws: Cluster Headaches, Citizen Science, and the Story of ClusterBusters, with Joanna Kempner, Ph.D. 1:01:36

2M ago1:01:36

1:01:36

In this episode, Joe interviews Joanna Kempner, Ph.D.: associate professor in the Department of Sociology at Rutgers University and author of the recently released, Psychedelic Outlaws: The Movement Revolutionizing Modern Medicine. The book profiles the history and groundbreaking work of ClusterBusters, a nonprofit researching and spreading awarene…

1
PT545 – Breathwork, Holding Space, and the Healing Power of Connection: Documenting the Dreamshadow Community, with Mustapha Khan 1:11:13

2M ago1:11:13

1:11:13

In this episode, Kyle interviews Mustapha Khan: Emmy Award-winning director with over 100 film and television credits, who has worked with clients such as Coca-Cola and Honda, and celebrities ranging from Maya Angelou to Snoop Dogg. Khan is finalizing a film about Lenny and Elizabeth Gibson and their ongoing work at Dreamshadow – the people and com…

1
Does This Drug Represent “A Paradigm Shift for Small Molecule Drug Development?” 28:01

2M ago28:01

28:01

NAMPT is a critical enzyme that regulates how cells use energy. It can also play an important role in the ability of cancer cells to survive, grow, and spread. While it’s been recognized as a potential target to treat certain cancers, developing NAMPT inhibitors have been challenging because they can disrupt energy metabolism in healthy cells. Reme…

1
PT544 – Psychedelics and Addiction Recovery: Microdosing and Redefining the Path to Sobriety, with Danielle Nova 1:04:58

2M ago1:04:58

1:04:58

In this episode, Joe interviews Danielle Nova: founder of Psychedelic Recovery, founding team member of Decriminalize Nature Oakland, and Executive Director of the San Francisco Psychedelic Society. As a recovering addict, Nova discusses how working with psychedelics helped her find her way to recovery, and how she's spreading that knowledge to oth…

1
PT543 – Empathy and Agency: Why Psychedelic Practitioners Need to be Trauma-Informed, with Deanna Rogers 1:18:25

2M ago1:18:25

1:18:25

In this episode of Vital Psychedelic Conversations, David interviews Deanna Rogers: Registered Clinical Counselor and Vital instructor. She discusses how trauma grows in our bodies, and the importance of practitioners and facilitators becoming trauma-informed before working with clients. She stresses the need to create the right conditions for clie…

1
Exploring the Promise and Peril of CRISPR 57:36

2M ago57:36

57:36

The emergence of CRISPR, a powerful tool for gene editing, promises to correct devastating genetic diseases, but it also raises concerns about how it will be used and who will make those decisions. Neal Baer, in his new book “The Promise and Peril of CRISPR,” brings together a series of essays by bioethicists, geneticists, and others who explore et…

1
PT542 – The Illinois CURE Act: Shaping the Future of Psychedelic Policy, with Jean Lacy & Representative La Shawn K. Ford 1:02:09

2M ago1:02:09

1:02:09

In this episode, Joe interviews Jean Lacy: Executive Director of the Illinois Psychedelic Society; and La Shawn K. Ford: 17-year member of the Illinois House of Representatives, representing the 8th District. Together, they are working on the CURE (Compassionate Use and Research of Entheogens) Act, which aims to decriminalize plant medicines and br…

1
PT541 – Regenerative Economics and Psychedelics: Creating More Connected Leadership, with Rachelle Sampson, Ph.D. & Bennet Zelner, Ph.D. 51:56

2M ago51:56

51:56

In this episode of Vital Psychedelic Conversations, David interviews Rachelle Sampson, Ph.D.: researcher and founder of Blue Prism Coaching; and Bennet Zelner, Ph.D.: researcher, speaker, and creator of the Pollination Approach. They are both Vital instructors and Associate Professors at the Robert H. Smith School of Business, University of Marylan…

1
Swimming in the Deep End of AI 59:08

2M ago59:08

59:08

Brendan Frey, founder and chief innovation officer of Deep Genomics, sits down with Amar Drawid to discuss how the company is using deep learning to leverage massive RNA biology datasets to drive the development of new therapies.Por Levine Media Group

1
Transforming Protein Engineering with Generative AI 35:47

3M ago35:47

35:47

Speeding Protein Engineering with Whether it’s the development of new biotherapeutics, or replacing hydrocarbons from their role in industrial manufacturing, engineering proteins suited for a task is a time consuming and expensive process. Cradle Bio has developed generative AI technology to accelerate protein engineering by reducing the number of …

1
PT540 – Ancestral Teachings for the Psychedelic Renaissance, with Alonso Del Río & Francisco Rivarola 44:57

3M ago44:57

44:57

As the psychedelic renaissance continues to spread throughout the West, we learn more about these substances and experiences every day. But are we losing the important ancestral teachings and Indigenous knowledge that got us here? In this episode, Kyle interviews Alonso Del Río: author, musician, filmmaker, founder of the Center for Healing and Con…

Podcasts que valem a pena ouvir

Podcasts sobre Levine Media Group

Podcasts que valem a pena ouvir

Guia rápido de referências